9781760835316 (ISBN)
http://nla.gov.au/nla.obj-3120167009
South Australia. Department for Health and Wellbeing, author, issuing body & Central Adelaide Local Health Network. Infectious Diseases, author. (2022). COVID-19 : pre-exposure prophylaxis (PrEP) with tixagevimab plus cilgavimab clinical guideline Retrieved May 22, 2025, from http://nla.gov.au/nla.obj-3120167009
South Australia. Department for Health and Wellbeing, author, issuing body and Central Adelaide Local Health Network. Infectious Diseases, author. COVID-19 : pre-exposure prophylaxis (PrEP) with tixagevimab plus cilgavimab clinical guideline [Adelaide]: [SA Health], 2022. Web. 22 May 2025 <http://nla.gov.au/nla.obj-3120167009>
South Australia. Department for Health and Wellbeing, author, issuing body & Central Adelaide Local Health Network. Infectious Diseases, author. 2022, COVID-19 : pre-exposure prophylaxis (PrEP) with tixagevimab plus cilgavimab clinical guideline [SA Health], [Adelaide] viewed 22 May 2025 http://nla.gov.au/nla.obj-3120167009
{{Citation
| author1=South Australia. Department for Health and Wellbeing, author, issuing body.
| author2=Central Adelaide Local Health Network. Infectious Diseases, author.
| title=COVID-19 : pre-exposure prophylaxis (PrEP) with tixagevimab plus cilgavimab clinical guideline
| year=2022
| section=1 online resource (14 pages)
| isbn=9781760835316
| edition=Version 1.2.
| location=[Adelaide]
| publisher=[SA Health]
| url=http://nla.gov.au/nla.obj-3120167009
| id=nla.obj-3120167009
| access-date=22 May 2025
| via=Trove
}}
Citations are automatically generated and may require some modification to conform to exact standards.
In Copyright
You may order a copy or use the online copy for research or study; for other uses Contact us.
Copyright status may not be correct if data in the record is incomplete or inaccurate. Other access conditions may also apply.
For more information please see: Copyright in library collections.